Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT06048224 · COMPLETED
Trial details
- NCT number
- NCT06048224
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-28
- Primary completion
- 2021-09-14
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.